HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women

NACompletedINTERVENTIONAL
Enrollment

467

Participants

Timeline

Start Date

April 4, 2012

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
HIV-1 Infection
Interventions
PROCEDURE

Cervical Cryotherapy

Participants had cervical cryotherapy within 7 days after study entry. The cryotherapy consists of two 3-minute freezes separated by 5 minutes of thawing.

PROCEDURE

Loop Electrosurgical Excision Procedure (LEEP)

Loop Electrosurgical Excision Procedure (LEEP): Participants found to have CIN2+ by biopsy had LEEP, an electro-surgical procedure used to treat high-grade cervical dysplasia.

Trial Locations (13)

411001

BJ Medical College CRS (31441), Pune

411026

National AIDS Research Institute Pune CRS (11601), Pune

Unknown

Gaborone Prevention/Treatment Trials CRS (12701), Gaborone

Molepolole Prevention/Treatment Trials CRS (12702), Molepolole

College of Med. JHU CRS (30301), Blantyre

University of North Carolina Lilongwe CRS (12001), Lilongwe

Investigaciones Medicas en Salud (INMENSA) (11302), San Isidro

Soweto ACTG CRS (12301), Johannesburg

Univ. of Witwatersrand CRS (11101), Johannesburg

UZ-Parirenyatwa CRS (30313), Harare

HT-6110

Les Centres GHESKIO CRS (30022), Port-au-Prince

18 PE

Asociacion Civil Impacta Salud y Educacion - Miraf CRS (11301), Lima

4013 SF

Durban Adult HIV CRS (11201), Durban

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

NETWORK

NCT01315353 - HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women | Biotech Hunter | Biotech Hunter